Martin L. Stockley

Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance

Diana Zatreanu, Helen M.R. Robinson, Omar Alkhatib et al. · Nature Communications · 2021 · 336 citations · Full text

Discovery of Potent Chromen-4-one Inhibitors of the DNA-Dependent Protein Kinase (DNA-PK) Using a Small-Molecule Library Approach

Ian R. Hardcastle, Xiaoling Cockcroft, Nicola J. Curtin et al. · Journal of Medicinal Chemistry · 2005 · 169 citations · Full text

Selective Benzopyranone and Pyrimido[2,1-<i>a</i>]isoquinolin-4-one Inhibitors of DNA-Dependent Protein Kinase:  Synthesis, Structure−Activity Studies, and Radiosensitization of a Human Tumor Cell Line in Vitro

Roger J. Griffin, Gabriele Fontana, Bernard T. Golding et al. · Journal of Medicinal Chemistry · 2004 · 141 citations · Full text

CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound

Ian T. Forbes, David G. Cooper, Emma K. Dodds et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 53 citations · Full text

Ccr2b Receptor Antagonists, Biochemistry, Functional Selectivity +9

Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta

Martin L. Stockley, Amanda Ferdinand, Giovanni Benedetti et al. · Journal of Medicinal Chemistry · 2022 · 41 citations · Full text